Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis.

JAMA Netw Open · 2019 · PMC6625073 · PMID 31290993

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Mutations in TP53 (DCB, 27 of 51 [53%]; NDB, 25 of 55 [45%]) and KRAS (DCB, 19 of 51 [37%]; NDB, 12 of 55 [22%]) were common and associated with increased responsiveness but did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.